Clinical trials
Recruiting Urogenital Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 2 |
| Anova Enterprises, Inc | 1 |
| Jade Biosciences, Inc. | 1 |
| K36 Therapeutics, Inc. | 1 |
| Nanopath, Inc | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| Sarah Schlegel | 1 |
| University of Virginia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Diseases | 10 |
| Female Urogenital Diseases | 5 |
| Male Urogenital Diseases | 5 |
| Neoplasms | 4 |
| Neoplasms by Site | 4 |
| Female Urogenital Diseases and Pregnancy Complications | 3 |
| Urogenital Neoplasms | 3 |
| Urologic Diseases | 3 |
| Autoimmune Diseases | 2 |
| Congenital Abnormalities | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.